Investigation into Synopsys, Inc. by Pomerantz LLP
Pomerantz LLP has announced an investigation on behalf of investors of Synopsys, Inc. (NASDAQ: SNPS), focusing on potential claims of securities fraud and unlawful business practices by the company and its executives. This inquiry arises after troubling financial reports emerged, prompting concerns among shareholders.
On September 9, 2025, Synopsys released its financial results for the third quarter of the 2025 fiscal year. During the announcement, the company’s CEO indicated that their Intellectual Property (IP) business had significantly underperformed against expectations. As a result, the outlook for the fourth quarter was revised to a more conservative stance, although the company reiterated its capability for continued profitable growth. This news was concerning enough to lead Baird, a well-known financial services company, to downgrade Synopsys's stock rating from "Outperform" to "Neutral," while also lowering its price target from $670 to $535.
The subsequent reaction from the market was swift. On September 10, Synopsys shares dropped by $216.59, equivalent to a staggering 35.84% plunge, closing at $387.78 per share. This sharp decline raised alarms among investors who may have suffered substantial losses.
Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class actions, established over 85 years ago by the respected Abraham L. Pomerantz, often called the dean of class action lawyers. The firm has a reputation for championing the rights of victims of corporate misconduct and has successfully secured numerous multimillion-dollar settlements for class members over the years.
Investors who may be impacted by the recent downturn in Synopsys are urged to reach out and potentially participate in any resulting class action. They can contact Danielle Peyton from Pomerantz LLP at [email protected] or 646-581-9980, extension 7980, to receive further information on their rights and possible actions.
Given the firm's history and dedication to holding corporations accountable for wrongdoing, this investigation marks a crucial step for affected investors seeking justice and recovery of their financial losses.
In summary, the scrutiny surrounding Synopsys highlights the fragile nature of investor trust and the significant impact a company’s performance can have on shareholder value. As this case unfolds, many will be watching closely to see how Synopsys navigates these allegations and the potential repercussions it may face in the legal landscape.
For more details about Pomerantz LLP and previous cases, visit
Pomerantz's official website.